Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Medical Equipments
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles. Hence, it is widely targeted for therapeutic treatments of Parkinson’s and Huntington’s disease. VMAT2 inhibitors block VMAT2 proteins and control the neurotransmission activity, thereby reducing the unwanted body movements caused by Huntington’s disease and tardive dyskinesia. VMAT2 inhibitors are widely used for the treatment of uncontrollable involuntary, repetitive body movements caused due to tardive dyskinesia and Huntington’s disease.
The global vesicular monoamine transporter-2 inhibitors market is driven primarily by rise in incidence of the diseases mentioned above. Huntington’s disease is a progressive brain disorder that causes involuntary body movement, loss of recognition ability, and emotional problems. Prevalence of this disease is high in the developed countries, especially in Europe. An estimated five to seven people per 100,000 are affected by Huntington’s disease in countries in the West. High prevalence of Huntington’s disease has been observed in Venezuela, where around 700 people per 100,000 have the disease. Tardive dyskinesia is a side effect of antipsychotic medications used for the treatment of schizophrenia and other mental health disorders. In the U.S., this disease occurs in 15% to 30% patients who have received long-term neuroleptic medication. Moreover, the investigational studies for the discovery of novel therapeutics using VMAT2 inhibitor to treat methamphetamine abuse are likely to boost demand during the forecast period. However, side effects of VMAT 2 inhibitors such as sleepiness, dry mouth, constipation, and heart conduction changes are likely to hamper the growth of the VMAT2 inhibitors market.
The global VMAT2 inhibitors market can be segmented based on application and region. In terms of application, the global market can categorized into Huntington’s disease and tardive dyskinesia. The tardive dyskinesia segment is projected to account for high market share by 2025. The segment is anticipated to record exponential growth rate during the forecast period. People with schizophrenia, bipolar disorders, and other neuropsychiatric disorders undergoing long-term medical treatments with antipsychotic medication are more likely to develop symptoms of tardive dyskinesia.
Geographically, the global VMAT2 inhibitors market can be segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. North America is expected to hold significant share of the global market by 2025. Large market share of the region is attributed to increase in number of patients with bipolar diseases, schizophrenia, and Huntington’s disease in this region. Europe is likely to record high CAGR during the forecast period. High prevalence of Huntington’s disease and rise in incidence of tardive dyskinesia are projected to drive the market in the region during the forecast period. The market in Asia Pacific is anticipated to expand at a moderate growth rate during the forecast period.
Key players operating in the global VMAT2 inhibitors market include Tocris Bioscience, Neurocrine Biosciences, Inc., Teva Pharmaceuticals Industries Ltd., EUSA Pharma (UK) Limited, and Lundbeck, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.